Results 191 to 200 of about 339,632 (390)

C1′‐Branched Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium Falciparum 6‐Oxopurine Phosphoribosyltransferase

open access: yesChemMedChem, EarlyView.
Novel C1'‐branched acyclic nucleoside phosphonates were synthesized. The compounds are inhibitors of Plasmodium falciparum and human 6‐oxopurine phosphoribosyltransferases with Ki values as low as 0.4 µM and 0.7 µM, respectively. A phosphonodiamidate prodrug exhibited IC50 = 4.3 µM against a drug‐sensitive strain of P.
Jan Frydrych   +11 more
wiley   +1 more source

Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou   +6 more
wiley   +1 more source

Role of the stage-regulated nucleoside transporter TbNT10 in differentiation and adenosine uptake in Trypanosoma brucei [PDF]

open access: yes, 2007
Al-Salabi   +25 more
core   +2 more sources

Identification of Candidate Blood Biomarkers of Recombinant Human Erythropoietin Administration Using Targeted Polar Metabolomics by HILIC‐MS/MS

open access: yesDrug Testing and Analysis, EarlyView.
Using targeted HILIC‐MS/MS metabolomics, inosine and hypoxanthine were identified as potential biomarkers of EPO administration. Their consistent and sensitive plasma responses highlight their promise for inclusion in the Athlete Biological Passport (ABP), warranting further investigation to enhance anti‐doping detection strategies. ABSTRACT Increasing
Olivier Salamin   +5 more
wiley   +1 more source

Nucleoside analogues for the treatment of coronavirus infections

open access: yesCurrent Opinion in Virology, 2019
A. Pruijssers, M. Denison
semanticscholar   +1 more source

5‐Bromo‐8‐Nitro‐1‐Naphthoic Acid as Protective Group for Alcohols Under Mitsunobu Conditions

open access: yesEuropean Journal of Organic Chemistry, EarlyView.
Protection of alcohols is carried out using the readily available 5‐bromo‐8‐nitro‐1‐naphthoic acid (NNapOH). Under Mitsunobu conditions, primary and secondary alcohols are converted into the corresponding esters, which are subsequently deprotected under mild reduction conditions. The use of the readily available 5‐bromo‐8‐nitro‐1‐naphthoic acid (NNapOH)
Estela Sánchez‐Santos   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy